Sotera Health Co
NASDAQ:SHC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.75
17.34
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Sotera Health Co
Sotera Health Co
Cash from Financing Activities
Sotera Health Co
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sotera Health Co
NASDAQ:SHC
|
Cash from Financing Activities
$266m
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$4.6B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$8.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-34%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$881.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$752m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-23%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$923m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
-18%
|
|
Sotera Health Co
Glance View
Nestled in the heart of the life sciences industry, Sotera Health Co. emerges as a pivotal player, ensuring safety where health meets innovation. The company's journey is one of dedication to safeguarding global health, primarily through its trio of core businesses: Sterigenics, Nordion, and Nelson Labs. With a focus on sterilization, gamma technology, and laboratory testing, these subsidiaries collectively empower Sotera Health to command a critical niche in the health sector. Sterigenics steps into the spotlight by providing sterilization solutions that employ cutting-edge methodologies, such as ethylene oxide and gamma irradiation, essential for decontaminating medical equipment and consumables. Nordion complements this by leading the charge in gamma technologies, offering isotopes that are vital not just for sterilization but also in cancer treatment. Meanwhile, Nelson Labs rounds off the triad by delivering extensive microbiological and analytical testing services, catering to the rigorous standards of medical device manufacturers and pharmaceutical companies globally. The company doesn't operate in isolation; instead, it forms an integral part of the healthcare supply chain. By ensuring that surgical instruments are free of pathogens and that various health products meet stringent safety standards, Sotera Health becomes indispensable to hospitals, clinics, and research facilities around the world. Financially, the revenue streams flow predominantly from multi-year contracts and long-term client relationships, which are testament to the critical value the company provides. As the medical landscape evolves, with increasing complexity and regulatory demands, Sotera Health's blend of technology, reliability, and compliance positions it not just as a vendor, but as a protector of public health. This role orchestrates a business model that not only thrives on the present-day needs but is poised for growth as global health and safety requirements expand.
See Also
What is Sotera Health Co's Cash from Financing Activities?
Cash from Financing Activities
266m
USD
Based on the financial report for Dec 31, 2023, Sotera Health Co's Cash from Financing Activities amounts to 266m USD.
What is Sotera Health Co's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
54%
Over the last year, the Cash from Financing Activities growth was 34%. The average annual Cash from Financing Activities growth rates for Sotera Health Co have been 54% over the past three years .
You don't have any saved screeners yet
